Ardelyx (NASDAQ:ARDX) Now Covered by Analysts at SVB LeerinkZolmax • 20 days ago
SVB Leerink started coverage on shares of Ardelyx (NASDAQ:ARDX - Free Report) in a research report released on Friday, Marketbeat reports. The firm issued an outperform rating and a $14.00 price...
Share to Feed
Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) has been assigned a consensus rating of "Buy" from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. Seven...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
SG Americas Securities LLC trimmed its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 49.9% in the fourth quarter, according to the company in its most recent 13F filing with the...
Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 36,310,000 shares, an...
Clay Northam Wealth Management LLC bought a new position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with...
This is a signal that ARDX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
WALTHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class...
Investors in Ardelyx Inc (ARDX) saw new options become available today, for the May 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARDX options chain...
This is a signal that ARDX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...